{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Denver",
      "state": "CO",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89550",
      "recalling_firm": "STAQ Pharma, Inc.",
      "address_1": "14135 E 42nd Ave Ste 50",
      "address_2": "N/A",
      "postal_code": "80239-5214",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "CO, OH, and TX.",
      "recall_number": "D-0633-2022",
      "product_description": "HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0104-05.",
      "product_quantity": "905 Syringes",
      "reason_for_recall": "Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A",
      "recall_initiation_date": "20220203",
      "center_classification_date": "20220225",
      "termination_date": "20220916",
      "report_date": "20220223",
      "code_info": "Lot Number: 21104221A, Expiration date: 05-22-2022"
    }
  ]
}